Recognized as the 2020 Pacific Northwest Entrepreneur of the Year and one of Forbes’ 2019 30 under 30 in science, McClain is nurturing his startup into the region’s most successful biotechnology company. By investigating and developing technologies, McLain is poised to drive down drug costs, speed drug development, and enable the scalable manufacture of next-generation therapeutics that otherwise may never make it past the lab. Investors and partners agree. AbSci has closed more than $100M in capital and has inked deals with global pharmaceutical partners.
McClain may be growing more than a budding biotech business.
“This region is an excellent area to establish our roots. Other successful biotech companies are actively considering locating to the area due to the favorable business environment and quality of life.”
Watch AbSci grow something special here. (absci.com)